Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02556177 · ClinicalTrials.gov registry record · NA
Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2
A NA study, sponsored by GE Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 477
- Enrollment target
NCT02556177 is a NA study that has completed, run by GE Healthcare. The registered enrollment target is 477 participants.
The verdict
NCT02556177, a NA study, has completed, sponsored by GE Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 477 participants
- Enrollment target
Study Summary
This is an open-label, non-randomized, prospective, multi-site, parallel group (segment), hypothesis-generating study designed to collect data that will aid in future scientific and engineering exploration of correlations between clinical neuropsychological assessments and GE Research Pack II advanced MR imaging in mTBI patients. The results are primarily intended for scientific inquiry and engineering development purposes, and may be used in future regulatory submissions.
Interventions
- PROCEDURE MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 477 participants |
| Start Date | 2015-11 |
| Est. Completion | 2018-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02556177
The ClinicalTrials.gov registry entry for NCT02556177 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 477 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GE Healthcare, which has 99 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MRI is the first listed.
NCT02556177 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02556177 about?
NCT02556177 is a clinical study titled "Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2". This is an open-label, non-randomized, prospective, multi-site, parallel group (segment), hypothesis-generating study designed to collect data that will aid in future scientific and engineering exploration of correlations between clinical neuropsychological assessments and GE Research Pack II advanc...
What is the current status of trial NCT02556177?
This trial is currently completed. It is a NA study. The enrollment target is 477 participants. The study started on 2015-11. Estimated completion is 2018-01-31.
What interventions are being tested in trial NCT02556177?
The interventions under investigation include: MRI (PROCEDURE).
Who is sponsoring clinical trial NCT02556177?
This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.